Authors : Bohissou FET; Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.; Institut de Recherche en Sciences de la Santé (IRSS)/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso.

Subjects: Tetrahydrofolate Dehydrogenase*/Tetrahydrofolate Dehydrogenase*/Tetrahydrofolate Dehydrogenase*/genetics ; Dihydropteroate Synthase*/Dihydropteroate Synthase*/Dihydropteroate Synthase*/genetics ; Mutation*

Source: Scientific reports [Sci Rep] 2024 Oct 16; Vol. 14 (1), pp. 24224. Date of Electronic Publication: 2024 Oct 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol.

Authors : Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), 06 BP 10248, Ouagadougou 06, Burkina Faso. .; Pouplin JNN

Subjects: Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/drug therapy ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/parasitology ; Primaquine*/Primaquine*/Primaquine*/pharmacokinetics

Source: Trials [Trials] 2024 Sep 03; Vol. 25 (1), pp. 583. Date of Electronic Publication: 2024 Sep 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Assessing the histidine-rich protein 2/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso.

Authors : Tarama CW; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.; Soré H

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/parasitology; Child

Source: Malaria journal [Malar J] 2023 Nov 29; Vol. 22 (1), pp. 363. Date of Electronic Publication: 2023 Nov 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

[Polymorphisms in Plasmodium falciparum parasites and mutations in the resistance genes Pfcrt and Pfmdr1 in Nanoro area, Burkina Faso].

Authors : Sondo P; Institut de Recherche en Sciences de la Santé, Unité de Recherche Clinique de Nanoro (IRSS-URCN), Bobo-Dioulasso, Burkina Faso.; Bihoun B

Subjects: Antimalarials/Antimalarials/Antimalarials/*pharmacology ; Malaria, Falciparum/Malaria, Falciparum/Malaria, Falciparum/*parasitology ; Plasmodium falciparum/Plasmodium falciparum/Plasmodium falciparum/*genetics

Source: The Pan African medical journal [Pan Afr Med J] 2021 Jun 10; Vol. 39, pp. 118. Date of Electronic Publication: 2021 Jun 10 (Print Publication: 2021).Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso.

Authors : Somé, A; Conrad, Melissa; Kabré, Zachari

Subjects: Burkina Faso; Plasmodium falciparum; antimalarial drugs

Source: Antimicrobial Agents and Chemotherapy. 68(4)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Authors : Francis Emmanuel Towanou Bohissou; Paul Sondo; Juliana Inoue

Subjects: Plasmodium falciparum; Pfdhfr; Pfdhps

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.

Authors : Yaro JB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.; Department of Biosciences, Durham University, Durham, UK.

Subjects: Seasons*; Amodiaquine/Amodiaquine/Amodiaquine/*therapeutic use ; Antimalarials/Antimalarials/Antimalarials/*therapeutic use

Source: Scientific reports [Sci Rep] 2022 Jan 26; Vol. 12 (1), pp. 1402. Date of Electronic Publication: 2022 Jan 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Editorial & Opinion

Is there evidence of anti-malarial multidrug resistance in Burkina Faso?

Authors : Rasmussen C; Global Malaria Programme, World Health Organization, Geneva, Switzerland. .; Ringwald P

Subjects: Drug Resistance, Multiple*; Antimalarials/Antimalarials/Antimalarials/*pharmacology ; Artemisinins/Artemisinins/Artemisinins/*pharmacology

Source: Malaria journal [Malar J] 2021 Jul 19; Vol. 20 (1), pp. 320. Date of Electronic Publication: 2021 Jul 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Genetic variation in the immune system and malaria susceptibility in infants: a nested case-control study in Nanoro, Burkina Faso.

Authors : Natama HM; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. .; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de La Santé, Nanoro, Burkina Faso. .

Subjects: Genetic Predisposition to Disease/Genetic Predisposition to Disease/Genetic Predisposition to Disease/*genetics ; Immunity, Innate/Immunity, Innate/Immunity, Innate/*genetics ; Malaria, Falciparum/Malaria, Falciparum/Malaria, Falciparum/*parasitology

Source: Malaria journal [Malar J] 2021 Feb 16; Vol. 20 (1), pp. 94. Date of Electronic Publication: 2021 Feb 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

Authors : Compaoré YD; Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Bobo Dioulasso, Burkina Faso. .; Zongo I

Subjects: Antimalarials/Antimalarials/Antimalarials/*adverse effects ; Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/*adverse effects ; Artesunate/Artesunate/Artesunate/*adverse effects

Source: Malaria journal [Malar J] 2021 Jan 29; Vol. 20 (1), pp. 64. Date of Electronic Publication: 2021 Jan 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.

Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol.

Assessing the histidine-rich protein 2/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso.

[Polymorphisms in Plasmodium falciparum parasites and mutations in the resistance genes Pfcrt and Pfmdr1 in Nanoro area, Burkina Faso].

Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso.

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.

Is there evidence of anti-malarial multidrug resistance in Burkina Faso?

Genetic variation in the immune system and malaria susceptibility in infants: a nested case-control study in Nanoro, Burkina Faso.

Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

اتصل بنا

اتبع